Erlocip 150 mg Tablet

Erlocip 150 mg Tablet Specification

Salt Composition
Erlotinib (150mg)

Origin
India

Dosage Form
Tablet

Indication
Non-small cell lung cancer, Pancreatic cancer

Enzyme Types
Erlocip 150 mg Tablet

Feature
Targeted therapy, inhibits EGFR tyrosine kinase

Application
Used as an oral anticancer agent

Physical Color/Texture
White to off-white, film-coated tablet

Storage Instructions
Cool & Dry Place

Shelf Life
24 months

ATC Code
L01EB02

Contraindications
Hypersensitivity to Erlotinib

Route of Administration
Oral

Prescription Status
Prescription only medication

Usage
Take as directed by a qualified oncologist

Marketed By
Cipla Ltd.

Warning
To be sold by retail on the prescription of an Oncologist only

Strength
150 mg

Packing Type
Blister pack

Pack Size
30 tablets per pack

Erlocip 150 mg Tablet Trade Information

Minimum Order Quantity
5000 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
3-4 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Erlocip 150 mg Tablet

Erlocip 150 MG Tablet is used in the treatment of??non-small cell lung cancer??and??pancreatic cancer. Erlocip 150 MG Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Targeted Therapy for Cancer Patients

Erlocip 150 mg Tablet offers a specialized approach in the treatment of non-small cell lung cancer and pancreatic cancer. By specifically inhibiting EGFR tyrosine kinase, the medication helps to slow down or stop the proliferation of cancer cells. This feature makes it a valuable component in modern oncology, providing patients with targeted therapy options prescribed by expert oncologists.

Proper Usage and Administration

This medication is intended for oral use and should be taken strictly as prescribed by a qualified oncologist. Compliance with professional directions ensures maximum efficacy and minimizes the risk of unwanted side effects. The blister pack ensures convenient storage and accurate dosing, enabling patients to easily track their medication regimen.

Safety Precautions and Storage

Erlocip 150 mg Tablet must be stored in a cool, dry environment and kept out of reach of children. It should never be used without a prescription, and is contraindicated in individuals with known hypersensitivity to Erlotinib. Observing all storage and usage guidelines preserves the medicine's integrity and ensures patient safety during treatment.

FAQ's of Erlocip 150 mg Tablet:

Q: How should I take Erlocip 150 mg Tablet for the best results?

A: Take Erlocip 150 mg Tablet orally exactly as prescribed by your oncologist. Swallow the tablet whole, preferably on an empty stomach, and follow your healthcare provider's instructions for timing and dosage.

Q: What is Erlocip 150 mg Tablet used for?

A: Erlocip 150 mg Tablet is primarily used for treating non-small cell lung cancer and pancreatic cancer. It works as a targeted anticancer agent by inhibiting EGFR tyrosine kinase, which disrupts the growth of cancer cells.

Q: When should Erlocip 150 mg Tablet be avoided?

A: This medication should be avoided if you have a known hypersensitivity to Erlotinib or any of its ingredients. Always inform your doctor of any allergies or adverse reactions to similar drugs before starting therapy.

Q: Where should I store my Erlocip 150 mg Tablet blister pack?

A: Store the blister pack in a cool and dry place, away from light and moisture. Keep it out of reach of children and do not use it beyond its 24-month shelf life.

Q: What is the process for obtaining Erlocip 150 mg Tablet?

A: Erlocip 150 mg Tablet is a prescription-only medication and must be obtained from a pharmacy with a valid prescription from a qualified oncologist. It is not available for over-the-counter purchase.

Q: What are the benefits of using Erlocip 150 mg Tablet?

A: The main benefit of Erlocip 150 mg Tablet is its targeted action against certain types of cancer cells, offering a modern and effective approach to cancer therapy. When taken as prescribed, it can help slow disease progression and improve patient outcomes.

Tell us about your requirement